Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 51:
52. The compound of claim 51, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
R2 is C6-C10 aryl, wherein the C6-C10 aryl is optionally substituted by 1, 2, 3, 4, or 5 independently selected R2d substituents;
at least one R2d is C1-C2 alkyl, wherein the C1-C2 alkyl is optionally substituted by 1, 2, 3, 4, or 5 independently selected R4a substituents; and
each R4a is independently halogen or OR8.